Top Story

Growth estimated in B-cell NHL treatment market value

August 30, 2014

The market value of B-cell non-Hodgkin’s lymphoma treatments will experience moderate growth across six major markets from $4.59 billion in 2013 to $5.41 billion by 2018, according to a report from GlobalData.

The research and consulting firm said that with the recent FDA approval of targeted B-cell receptor inhibitors ibrutinib (Imbruvica; Pharmacyclics, Janssen) and idelalisib (Zydelig, Gilead Sciences), the global NHL treatment paradigm will undergo a dramatic shift away from chemoimmunotherapy regimens.

In the Journals

S-1 noninferior to UFT/LV for stage III colon cancer

August 29, 2014
Adjuvant chemotherapy with the oral fluoropyrimidine derivative S-1 conferred similar DFS rates as tegafur-uracil plus leucovorin among patients with stage III

Survey shows doctors predominantly lead ACOs

August 29, 2014
Accountable Care Organizations are largely led by physicians or physician and hospital partnerships, according to data published in Health Affairs. “The broad…
In the Journals

Sunitinib active in meningioma

August 29, 2014
Sunitinib demonstrated encouraging activity in patients with recurrent and progressive meningioma, according to results of a prospective, multicenter, single-arm phase 2…
More News Headlines »
CME

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

8/16/2014
The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
Meeting News Coverage Video
figure

Docetaxel plus ADT improved OS in metastatic prostate cancer

June 24, 2014
CHICAGO — Donald L. Trump, MD, FACP, president and CEO at Roswell Park Cancer Institute and HemOnc Today
More »
CME CNE

Treatment Decision-Making through the Spectrum of MDS: Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

8/20/2014
MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »